Home Amazon Eyes Pharmacy Expansion: Filing Reveals Ambitions to Disrupt $200 Billion Drug Market

Amazon Eyes Pharmacy Expansion: Filing Reveals Ambitions to Disrupt $200 Billion Drug Market

May 18, 2017 18:42 CST Updated 18:42

Amazon has transformed the way people across the United States—and indeed around the world—shop, and entered the streaming media landscape with Prime Video. Recently, this e-commerce and technology giant appears to have set its sights on the highly challenging healthcare sector, poised to make significant inroads into the pharmaceutical industry.


a7da30c1-3984-11e7-8e5b-3102dfaf568b_600x400 (1).jpg

 

According to CNBC’s report on May 16 local time, Jeff Bezos is planning to recruit a group of pharmaceutical talents, includingRecruit the prospective General Manager of the future pharmaceutical branch, as well as personnel for various pharmaceutical-related departments.

 

The report also stated that,Amazon’s Japan website has added shipping for pharmaceuticals and cosmetics to its “Prime Now” option, and a new pharmaceutical category page has also been launched.. In line with Amazon’s practice, new services are typically tested on websites outside the United States before their official launch.

 

In the stock market, some large pharmacy chains were immediately affected—CVS and Walgreens both closed down more than 3%.

 

>>>>

Not Content with Just Selling Vitamins, Amazon Continues to “Poach” Business from Pharmacies


It is easy to see why Amazon is interested in the pharmacy sector. For instance, CVS’s mail-order prescription drug business generated over $10 billion in revenue in the first quarter alone. If Amazon is considering entering the broader pharmacy benefit management (PBM) market—reports indicate it is recruiting talent in this area—it would be venturing into an industry that generated more than $200 billion in revenue last year.

 

On the other hand, if Amazon can leverage its experience to significantly improve current mail-order pharmacy services, it could also have a substantial impact on retail pharmacies. Amazon has already exerted some influence on traditional pharmacy businesses, such as through the sale of its private-label vitamins, batteries, and groceries on its e-commerce platform. However, pharmaceutical sales represent a more lucrative target, accounting for the majority of revenue for large U.S. pharmacy chains.

 

Currently, the majority of people still purchase prescription medications at brick-and-mortar pharmacies. In the first quarter, only 14.5% of CVS Pharmacy’s pharmaceutical reimbursements were processed through mail-order channels. Therefore, it is possible that Amazon’s target is to establish its own physical pharmacy network.

 

Stephen Buck, founder of healthcare company GoodRx, stated, “I believe Amazon will bring greater transparency to drug prices.”

 

>>>>

Can Amazon, Which Can Sell Anything, Succeed in Selling Drugs?


Leveraging its scale and strength, Amazon has always been fearless in exploring new frontiers. In the past, many believed that competing for market share was virtually impossible given Microsoft’s dominance in business computing. Yet Amazon succeeded: its AWS (Amazon Web Services) generated over $13 billion in revenue in the past year, establishing itself as a major player in the rapidly growing cloud computing market.

 

However, despite the fact that companies with formidable operational capabilities like Amazon are enough to intimidate any competitor (and their investors), breaking into the pharmaceutical industry is easier said than done. Drug distribution faces numerous challenges. First, the transportation of pharmaceuticals is subject to far more regulatory restrictions than ordinary goods. Furthermore, Amazon must contend with existing health insurance companies and Pharmacy Benefit Managers (PBMs) in the market, as managing drug profits and controlling costs while improving efficiency—core functions of PBMs—are not Amazon’s areas of expertise.

 

But at the same time, do not forget that Amazon’s core competency lies in selling virtually anything. The annual gross merchandise volume generated on its platform is unmatched by any other company, including chain pharmacies. With significant advantages over potential pharmacy competitors in terms of rapid delivery and customer experience, Amazon is well-positioned to capitalize on this edge. If it can overcome the many regulatory barriers within the pharmaceutical industry, it may rapidly penetrate the markets for online and mail-order prescription drugs.

 

“Amazon’s goal is to dominate the world, and it has indeed achieved success step by step in every sector it has chosen to enter,” remarked a CNBC reporter.


Source: CNBC, Forbes, etc.